Whole-Body Hyperthermia May Help Ease Depression Symptoms

This article originally appeared here.
Share this content:
Whole-Body Hyperthermia May Help Ease Depression Symptoms
Whole-Body Hyperthermia May Help Ease Depression Symptoms

MONDAY, May 16, 2016 (HealthDay News) -- Whole-body hyperthermia (WBH) may ease depression symptoms for up to six weeks, according to a study published online May 12 in JAMA Psychiatry to coincide with the annual meeting of the Society of Biological Psychiatry, held from May 12 to 14 in Atlanta.

Researchers evaluated 29 patients (18 to 65 years of age) who were deemed medically healthy, met criteria for major depressive disorder, were free of psychotropic medication use, and had a baseline 17-item Hamilton Depression Rating Scale score of 16 or greater. The team conducted a six-week, randomized, double-blind study at a university-based medical center comparing WBH with a sham treatment.

One week after treatment, the researchers re-evaluated each participant's depression symptoms. Additional evaluations were conducted every two weeks for six weeks. The researchers found that 60 percent of the patients responded to treatment and 40 percent met the criteria for remission from their depression. The real hyperthermia therapy improved depression scores a week later by an average of 5.67 points above that produced by the sham treatment. At six weeks after treatment, the real treatment had still improved depression scores by 4.83 points.

"We were surprised to see that the effect (of reduced depression symptoms) was still present six weeks after the initial treatment," study author Charles Raison, M.D., of the University of Wisconsin-Madison, said in a university news release. Self-reports from the volunteers also showed their symptoms of depression had eased slightly. The participants reported only minor adverse effects from the treatment.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »